Takara Bio Inc. (OTCMKTS:TKBIF – Get Free Report) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totaling 7,988 shares, a drop of 90.1% from the April 30th total of 80,646 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ? days.
Takara Bio Price Performance
Shares of TKBIF opened at $7.30 on Thursday. The firm’s 50 day simple moving average is $7.30 and its 200 day simple moving average is $12.24. Takara Bio has a 1-year low of $5.00 and a 1-year high of $7.30.
Takara Bio Company Profile
Takara Bio Inc, a subsidiary of Takara Holdings Inc, is a global provider of innovative biotechnological products and services. Headquartered in Kusatsu, Shiga, Japan, the company specializes in developing and marketing reagents and instruments for molecular biology, cell biology and genomic research. With roots tracing back to Takara Shuzo Co, Ltd.’s life sciences division, Takara Bio has leveraged decades of experience to support scientific discovery and biopharmaceutical development.
Takara Bio’s core offerings include polymerase chain reaction (PCR) enzymes and kits, DNA and RNA purification systems, cloning and gene expression reagents, and advanced genome editing tools such as CRISPR/Cas systems.
Recommended Stories
- Five stocks we like better than Takara Bio
- Dick’s Sporting Goods Isn’t Done Winning Yet
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
Receive News & Ratings for Takara Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takara Bio and related companies with MarketBeat.com's FREE daily email newsletter.
